Wu Hua Medicine: plans to distribute a cash dividend of RMB 1.46 per 10 shares to all shareholders.

The announcement of Wohua Pharmaceuticals stated that the net profit attributable to the shareholders of the listed company in the consolidated financial statements for the year 2025 was 95.7153 million yuan, and the distributable profits of the parent company were 91.2595 million yuan. The company's distributable profits were 84.661 million yuan. The company plans to use a total share capital of 577 million shares as of December 31, 2025, and distribute a cash dividend of 1.46 yuan per 10 shares to all shareholders, totaling 84.2726 million yuan in cash dividends, without bonus shares or capitalization of reserves. After the implementation of this profit distribution plan, the total cash dividends for the year 2025 will be 154 million yuan, accounting for 160.41% of the net profit attributable to the shareholders of the listed company for the year.